Boston, MA (PRWEB) May 23, 2013
The first annual Healthcare Venture Philanthropy Summit is taking place today in Boston. The event brings together thought leaders from healthcare, philanthropy, venture capital and research. The goal of the summit is to openly discuss and seek creative ways by which organizations can invest in the advancement of science towards the development of new therapies for patients.
“We believe this summit can serve as a model of how medical research, business and philanthropy can work together.” Donna K. Arnett, President, American Heart Association. “By making funding available at a critical moment in the development of new technology we can accelerate the research and innovation needed to improve people’s health and well-being.” Michael Greeley, General Partner, Flybridge Capital Partners and Board Member, New England Venture Capital Association.
The summit will include a series of panels discussing best practices that will allow the organizations to leverage the philanthropic dollar and establish novel ways to collaborate to advance patient care. The panels will address topics such as:
- Investment models in Venture Philanthropy
- Measuring the impact of Venture Philanthropy
- Roadmap to success –getting products to patients
“A discussion on best practices in the industry is very timely.” Louis J. DeGennaro, Chief Mission Officer, The Leukemia & Lymphoma Society. The Healthcare Venture Philanthropy Summit is the first of, what is hoped to be, many ongoing discussions.
The outcome of the summit will be captured in a publication that will be available through Broadview Ventures, the hosts and organizers of the summit. To order an advance copy of the white paper email whitepaper(at)broadviewventures(dot)org or click on the Healthcare Venture Philanthropy Summit link on the BroadviewVentures.org website.
Fondation Leducq created, Broadview Ventures, Inc., to accelerate the translation of scientific discoveries into clinical benefit in cardiovascular and neurovascular disease through targeted investment in support of early stage technology. Broadview Ventures is designed to help overcome the problem of the so-called "translation gap," where very early stage companies find that their research is too advanced for traditional academic funding, but not sufficiently developed to attract conventional venture capital investment. For inquiries and more information please email: info(at)broadviewventures(dot)org